Obesity, blood vessels and metabolic syndrome

Acta Physiologica

Volumn 203, Issue 1, 2011, Pages 279-286

  Tesauro, M ^a   Cardillo, C ^b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Endothelium; Insulin; Metabolic syndrome; Obesity; Oxidative stress; Vascular reactivity

Indexed keywords

ADIPONECTIN; ENDOTHELIN 1; FATTY ACID; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RESISTIN; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ADVENTITIA; BLOOD VESSEL; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; BODY MASS; CYTOKINE PRODUCTION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; MACROPHAGE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; REVIEW; SKELETAL MUSCLE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; BLOOD VESSELS; HUMANS; METABOLIC SYNDROME X; OBESITY;

EID: 80051668515     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2011.02290.x     Document Type: Review

References (62)

1. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., Fruchart, J.C., James, W.P., Loria, C.M. & Smith, S.C. Jr. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640-1645.
2. Baron, A.D. & Clark, M.G. 1997. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 17, 487-499.
3. Baron, A.D., Steinberg, H.O., Chaker, H., Leaming, R., Johnson, A. & Brechtel, G. 1995. Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96, 786-792.
4. Bredt, D.S. & Snyder, S.H. 1994. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63, 175-195.
5. Cardillo, C., Kilcoyne, C.M., Nambi, S.S., Cannon, R.O., 3rd, Quon, M.J. & Panza, J.A. 1998. Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm. Hypertension 32, 740-745.
6. Cardillo, C., Nambi, S.S., Kilcoyne, C.M., Choucair, W.K., Katz, A., Quon, M.J. & Panza, J.A. 1999. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 100, 820-825.
7. Cardillo, C., Campia, U., Iantorno, M. & Panza, J.A. 2004. Enhanced vascular activity of endogenous endothelin-1 in obese hypertensive patients. Hypertension 43, 36-40.
8. Clark, M.G. 2008. Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 295, E732-E750.
9. Clark, M.G., Wallis, M.G., Barrett, E.J., Vincent, M.A., Richards, S.M., Clerk, L.H. & Rattigan, S. 2003. Blood flow and muscle metabolism: a focus on insulin action. Am J Physiol Endocrinol Metab 284, E241-E258.
10. Clerk, L.H., Vincent, M.A., Jahn, L.A., Liu, Z., Lindner, J.R. & Barrett, E.J. 2006. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes 55, 1436-1442.
11. Davda, R.K., Stepniakowski, K.T., Lu, G., Ullian, M.E., Goodfriend, T.L. & Egan, B.M. 1995. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26, 764-770.
12. De Keulenaer, G.W., Alexander, R.W., Ushio-Fukai, M., Ishizaka, N. & Griendling, K.K. 1998. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329, 653-657.
13. Djaberi, R., Schuijf, J.D., van Werkhoven, J.M., Nucifora, G., Jukema, J.W. & Bax, J.J. 2008. Relation of epicardial adipose tissue to coronary atherosclerosis. Am J Cardiol 102, 1602-1607.
14. Dresner, A., Laurent, D., Marcucci, M., Griffin, M.E., Dufour, S., Cline, G.W., Slezak, L.A., Andersen, D.K., Hundal, R.S., Rothman, D.L., Petersen, K.F. & Shulman, G.I. 1999. Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103, 253-259.
15. Eringa, E.C., Stehouwer, C.D., van Nieuw Amerongen, G.P., Ouwehand, L., Westerhof, N. & Sipkema, P. 2004. Vasoconstrictor effects of insulin in skeletal muscle arterioles are mediated by ERK1/2 activation in endothelium. Am J Physiol Heart Circ Physiol 287, H2043-H2048.
16. Galic, S., Oakhill, J.S. & Steinberg, G.R. 2010. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 316, 129-139.
17. Gao, Y.J., Zeng, Z.H., Teoh, K., Sharma, A.M., Abouzahr, L., Cybulsky, I., Lamy, A., Semelhago, L. & Lee, R.M. 2005. Perivascular adipose tissue modulates vascular function in the human internal thoracic artery. J Thorac Cardiovasc Surg 130, 1130-1136.
18. Greenstein, A.S., Khavandi, K., Withers, S.B., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A.P., Pemberton, P.W., Malik, R.A. & Heagerty, A.M. 2009. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 119, 1661-1670.
19. Grundy, S.M., Brewer, H.B., Jr, Cleeman, J.I., Smith, S.C., Jr & Lenfant, C. 2004. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438.
20. deHaan, C.H., van Dielen, F.M., Houben, A.J., de Leeuw, P.W., Huvers, F.C., De Mey, J.G., Wolffenbuttel, B.H. & Schaper, N.C. 1997. Peripheral blood flow and noradrenaline responsiveness: the effect of physiological hyperinsulinemia. Cardiovasc Res 34, 192-198.
21. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M. & Shimomura, I. 2007. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56, 901-911.
22. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F. & Spiegelman, B.M. 1996. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271, 665-668.
23. Huang, P.L. 2005. Unraveling the links between diabetes, obesity, and cardiovascular disease. Circ Res 96, 1129-1131.
24. deJongh, R.T., Serne, E.H., Ijzerman, R.G., de Vries, G. & Stehouwer, C.D. 2004. Free fatty acid levels modulate microvascular function: relevance for obesity-associated insulin resistance, hypertension, and microangiopathy. Diabetes 53, 2873-2882.
25. de Jongh, R.T., Serné, E.H., IJzerman, R.G., de Vries, G. & Stehouwer, C.D. 2004. Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 109, 2529-2535.
26. Kahn, B.B. & Flier, J.S. 2000. Obesity and insulin resistance. J Clin Invest 106, 473-481.
27. Kim, J.A., Montagnani, M., Koh, K.K. & Quon, M.J. 2006. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113, 1888-1904.
28. Laakso, M., Edelman, S.V., Brechtel, G. & Baron, A.D. 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 85, 1844-1852.
29. Lau, D.C., Dhillon, B., Yan, H., Szmitko, P.E. & Verma, S. 2005. Adipokines: molecular links between obesity and atherosclerosis. Am J Physiol Heart Circ Physiol 288, H2031-H2041.
30. Lee, D.E., Kehlenbrink, S., Lee, H., Hawkins, M. & Yudkin, J.S. 2009. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab 296, E1210-E1229.
31. Levin, E.R. 1995. Endothelins. N Engl J Med 333, 356-363.
32. Lind, L. & Lithell, H. 1993. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 125, 1494-1497.
33. Lteif, A., Vaishnava, P., Baron, A.D. & Mather, K.J. 2007. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes 56, 728-734.
34. Lu, G., Greene, E.L., Nagai, T. & Egan, B.M. 1998. Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells. Hypertension 32, 1003-1010.
35. Mather, K.J., Lteif, A., Steinberg, H.O. & Baron, A.D. 2004. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53, 2060-2066.
36. Mohamed, F., Monge, J.C., Gordon, A., Cernacek, P., Blais, D. & Stewart, D.J. 1995. Lack of role for nitric oxide (NO) in the selective destabilization of endothelial NO synthase mRNA by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol 15, 52-57.
37. Perticone, F., Ceravolo, R., Candigliota, M., Ventura, G., Iacopino, S., Sinopoli, F. & Mattioli, P. 2001. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress. Diabetes 50, 159-165.
38. Piatti, P.M., Monti, L.D., Conti, M., Baruffaldi, L., Galli, L., Phan, C.V., Guazzini, B., Pontiroli, A.E. & Pozza, G. 1996. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans. Diabetes 45, 316-321.
39. Rask-Madsen, C., Dominguez, H., Ihlemann, N., Hermann, T., Kober, L. & Torp-Pedersen, C. 2003. Tumor necrosis factor-alpha inhibits insulin's stimulating effect on glucose uptake and endothelium-dependent vasodilation in humans. Circulation 108, 1815-1821.
40. Saltiel, A.R. & Kahn, C.R. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414, 799-806.
41. Schinzari, F., Tesauro, M., Rovella, V., Galli, A., Mores, N., Porzio, O., Lauro, D. & Cardillo, C. 2010. Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome. Am J Physiol Endocrinol Metab 299, 947-952.
42. Shulman, G.I. 2000. Cellular mechanisms of insulin resistance. J Clin Invest 106, 171-176.
43. Steinberg, H.O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G. & Baron, A.D. 1996. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97, 2601-2610.
44. Steinberg, H.O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B. & Baron, A.D. 1997. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100, 1230-1239.
45. Tack, C.J., Lutterman, J.A., Vervoort, G., Thien, T. & Smits, P. 1996. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans. Hypertension 28, 426-432.
46. Tesauro, M., Schinzari, F., Iantorno, M., Rizza, S., Melina, D., Lauro, D. & Cardillo, C. 2005. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112, 2986-2992.
47. Tesauro, M., Schinzari, F., Rovella, V., Melina, D., Mores, N., Barini, A., Mettimano, M., Lauro, D., Iantorno, M., Quon, M.J. & Cardillo, C. 2008. Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome. Diabetes Care 31, 1439-1441.
48. Tesauro, M., Schinzari, F., Rovella, V., Di Daniele, N., Lauro, D., Mores, N., Veneziani, A. & Cardillo, C. 2009. Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. Hypertension 54, 995-1000.
49. Van Guilder, G.P., Hoetzer, G.L., Dengel, D.R., Stauffer, B.L. & DeSouza, C.A. 2006. Impaired endothelium-dependent vasodilation in normotensive and normoglycemic obese adult humans. J Cardiovasc Pharmacol 47, 310-313.
50. Vicent, D., Ilany, J., Kondo, T., Naruse, K., Fisher, S.J., Kisanuki, Y.Y., Bursell, S., Yanagisawa, M., King, G.L. & Kahn, C.R. 2003. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest 111, 1373-1380.
51. Vincent, M.A., Barrett, E.J., Lindner, J.R., Clark, M.G. & Rattigan, S. 2003. Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 285, E123-E129.
52. Wang, C.P., Hsu, H.L., Hung, W.C., Yu, T.H., Chen, Y.H., Chiu, C.A., Lu, L.F., Chung, F.M., Shin, S.J. & Lee, Y.J. 2009. Increased epicardial adipose tissue volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) 70, 876-882.
53. Watanabe, S., Tagawa, T., Yamakawa, K., Shimabukuro, M. & Ueda, S. 2005. Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 25, 2376-2380.
54. Wellen, K.E. & Hotamisligil, G.S. 2003. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112, 1785-1788.
55. Yach, D., Stuckler, D. & Brownell, K.D. 2006. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12, 62-66.
56. Yki-Jarvinen, H. & Utriainen, T. 1998. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia 41, 369-379.
57. Yoshizumi, M., Perrella, M.A., Burnett, J.C., Jr & Lee, M.E. 1993. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73, 205-209.
58. Yudkin, J.S., Eringa, E. & Stehouwer, C.D. 2005. "Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 365, 1817-1820.
59. Zeng, G., Nystrom, F.H., Ravichandran, L.V., Cong, L.N., Kirby, M., Mostowski, H. & Quon, M.J. 2000. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101, 1539-1545.
60. Zhang, L., Wheatley, C.M., Richards, S.M., Barrett, E.J., Clark, M.G. & Rattigan, S. 2003. TNF-alpha acutely inhibits vascular effects of physiological but not high insulin or contraction. Am J Physiol Endocrinol Metab 285, E654-E660.
61. Zhang, L., Vincent, M.A., Richards, S.M., Clerk, L.H., Rattigan, S., Clark, M.G. & Barrett, E.J. 2004. Insulin sensitivity of muscle capillary recruitment in vivo. Diabetes 53, 447-453.
62. Ziccardi, P., Nappo, F., Giugliano, G., Esposito, K., Marfella, R., Cioffi, M., D'Andrea, F., Molinari, A.M. & Giugliano, D. 2002. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105, 804-809.